MedTrace Logo

A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking

NCT01076283 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2013-10-17

Study results available
· View outcomes & findings →

Summary

This pilot trial has the goal to demonstrate the feasibility of a study to test the effects of baclofen in a laboratory experiment using cue-reactivity and alcohol-self administration paradigms in non-treatment seeking alcohol-dependent subjects.

Conditions

  • Alcoholism

Interventions

DRUG

Baclofen

Baclofen 10mg t.i.d.

DRUG

Cyproheptadine

'active' placebo

Sponsors & Collaborators

  • Brown University

    lead OTHER

Principal Investigators

  • Lorenzo Leggio, M.D., M.Sc. · Brown University Center for Alcohol and Addiction Studies

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-04-30
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01076283 on ClinicalTrials.gov